1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Philippines Pharmaceuticals and Healthcare Report Q2 2016

Philippines Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 98 pages

Includes 3 FREE quarterly updates

BMI View: The relative distribution of diseases in the Philippines will remain favourable for multinationaldrugmakers. Chronic conditions such as cancer, cardiovascular disease and diabetes will drive demand forhealthcare services and medicines. Access to medicines will be strengthened by the continued expansion ofuniversal healthcare in the country. However, price caps on high-value medicines and poor intellectualproperty protection continue to limit commercial opportunities for innovative drug manufacturers.

Headline Expenditure Projections

- Pharmaceuticals: PHP150.4bn (USD3.3bn) in 2015, rising to PHP156.3bn (USD3.3bn) in 2016; +3.9%in local currency terms and -1.3% in US dollar terms. Forecast revised downwards slightly from lastquarter.

- Healthcare: PHP628.3bn (USD13.9bn) in 2015, rising to PHP700.4bn (USD14.7bn) in 2016; +11.5% inlocal currency terms and +5.9% in US dollar terms. Revised upwards from last quarter.

Table Of Contents

Philippines Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Philippines 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2012-2020) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2012-2020) 28
OTC Drug Market Forecast 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2012-2020) 31
Pharmaceutical Trade Forecast 32
Table: Pharmaceutical Trade Data And Forecasts (Philippines 2014-2020) 35
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Philippines 2014-2020) 35
Industry Risk/Reward Index 36
Asia Pacific Risk/Reward Index 36
Philippines Risk/Reward Index 42
Rewards 42
Risks 43
Regulatory Review 44
Intellectual Property Issues 48
Pricing Regime 51
Reimbursement Regime 55
Market Overview 56
Healthcare Sector 57
Table: Healthcare Resources (Philippines 2010-2015) 61
Table: Healthcare Personnel (Philippines 2010-2015) 61
Table: Healthcare Activity (Philippines 2010-2015) 62
Health Insurance 62
Clinical Trials 68
Epidemiology 69
Competitive Landscape 71
Research-Based Industry 71
Table: Multinational Market Activity 71
Generic Drugmakers 72
Pharmaceutical Distribution 73
Pharmaceutical Retail Sector 75
Table: Overview Of BnB, BNB and P100 Programme 78
Table: Cost Of Generic Drugs In Philippines (PHP) 78
Table: Number Of BnBs And BNBs In Selected Philippine Regions 79
Company Profile 80
GlaxoSmithKline Philippines 80
Novartis 83
Demographic Forecast 87
Table: Population Headline Indicators (Philippines 1990-2025) 88
Table: Key Population Ratios (Philippines 1990-2025) 88
Table: Urban/Rural Population and Life Expectancy (Philippines 1990-2025) 89
Table: Population By Age Group (Philippines 1990-2025) 89
Table: Population By Age Group % (Philippines 1990-2025) 90
Glossary 92
Methodology 94
Pharmaceutical Expenditure Forecast Model 94
Healthcare Expenditure Forecast Model 94
Notes On Methodology 95
Risk/Reward Index Methodology 96
Index Overview 97
Table: Pharmaceutical Risk/Reward Index Indicators 97
Indicator Weightings 98

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.